Alcon Inc. (SWX:ALC)

Market Cap	30.49B -24.1%
Revenue (ttm)	8.25B +4.9%
Net Income	777.09M -3.7%
EPS	1.57 -3.4%
Shares Out	487.43M
PE Ratio	39.85
Forward PE	23.32
Dividend	0.28 (0.45%)
Ex-Dividend Date	May 13, 2025

Volume	54,330
Average Volume	1,180,646
Open	62.52
Previous Close	62.56
Day's Range	62.08 - 62.62
52-Week Range	57.68 - 85.16
Beta	0.70
RSI	45.87
Earnings Date	Feb 25, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,942
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: ALC

Financial Performance

In 2025, Alcon's revenue was $10.40 billion, an increase of 4.94% compared to the previous year's $9.91 billion. Earnings were $980.00 million, a decrease of -3.73%.

Financial numbers in USD